"The credit turmoil that the world is seeing now is clearly the worst in history," says Habil Khorakiwala, executive chairman, Wockhardt. He should know, as his company finds itself in trouble over a Rs 3,400 crore debt burden.
Most feel as the movement of people normalises, the in-patient volumes in hospitals will grow and by the end of May, occupancy should be around 50 per cent, and 75 per cent over a period of time.
The Tata Institute of Social Sciences (TISS) is brimming with ideas and concrete plans for the new year and ahead
A team of cardiologists at the Wockhardt Hospital performed bypass surgery on the 15-month-old baby, the first of its kind in the country and one of the few such cases in the world.
He urged former defence health services personnel, nurses and ward boys who have retired from service and those who are trained in medical service but don't have jobs to come forward to help the state in the "war" against coronavirus.
Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.
The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.
Wockhardt Hospitals will expand to 10 to 15 hospitals over the next few years
The number of dollar billionaires in India has risen to 55 this year from 46 last year.
Wokhardt Life Sciences surged on Tuesday after the company's results indicated that it had soared strongly into the black from losses in the previous corresponding quarter.
Three doctors and 26 nurses have tested positive for novel coronavirus in Wockhardt Hospital in Mumbai's Mumbai Central area.
The drug regulator recently asked some domestic companies to cut prices of insulin while MNCs, which are major players, are allowed to set their own price for the drug.
Amul is the most affordable of baby food brands at Rs 250-270 for a one-kg pack and Rs 130-35 for 500 grammes.
'Is it advisable to have more number of scrips in small quantities or a few scrips in big quantities?'
These companies gave annualised returns of 11% on an average in the last five years, while shareholders of family-owned companies saw 5% annualised erosion
Wockhardt slumped 6% to Rs 389.50 on Friday after it declared a 43.8% drop in net profit for Q4 ended 31 December 2002.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
Another cap for imported insulin; domestic manufacturers cry foul.
Indian auto and pharma industries import several critical components and raw materials from China.
IT, pharma and FMCG stocks are the top performers in 2013.
Naukri.com's Hiring Outlook Survey for 2020 reveals the jobs and sectors that saw a surge in demand during the pandemic.
Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.
The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).
It may be Doktor Mom in Russia, or Farex in India.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations
Deals worth nearly $17 billion have got cancelled including -- the $14.5 billion Reliance-LyondellBasell deal, the $2 billion Reliance-Value Creation transaction, the $12 million PVR-DT Cinemas deal and the $130 million Wockhardt-Abbott Laboratories deal.
Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.
Year 2008 results of India's largest drug maker, Ranbaxy Laboratories, and Wockhardt were also impacted by forex losses. Companies such as Aurobindo and Orchid are also expected to post forex losses, say analysts.
Mahindra Satyam has approached the Commerce Ministry for more time to develop the three IT Special Economic Zones in Andhra Pradesh as it has decided to go slow on its expansion plans due to the slowdown.
This increase is despite the decreased growth of drug sales in the US - the world's largest market - which has seen a tightening of regulations and aggressive competition.
India emerging as a big global destination for contract manufacturing, unlike R&D outsourcing.
Leading Indian drug majors, such as Ranbaxy Laboratories, Dr Reddy's Laboratories, Piramal Healthcare and Wockhardt, are in-licensing popular products from overseas drug makers to boost their domestic sales.
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
The burgeoning Indian market, if handled smartly, offers a challenging opportunity for value creation.
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
In the growth years of 2005 to 2008,companies were busy shopping abroad to expand their global footprint. It's the turn of overseas companies now to buy Indian assets aggressively.
"Our intention has always been to provide value-for-money services," Shivinder Mohan Singh, MD, Fortis Healthcare.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances